Lung Neoplasms
340
30
44
165
Key Insights
Highlights
Success Rate
85% trial completion
Published Results
37 trials with published results (11%)
Research Maturity
165 completed trials (48% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.5%
29 terminated out of 340 trials
85.1%
-1.5% vs benchmark
7%
24 trials in Phase 3/4
22%
37 of 165 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 165 completed trials
Clinical Trials (341)
Benchmarking Large Language Models Against Tumour Boards for Oncology Treatment Recommendations
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
Empowering Patients' Lung Cancer Screening Uptake (Empower LCS/Call+)
Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada
Patient-Specific 3D Model-Assisted Preoperative Consultation for Thoracoscopic Lung Resection
LungVision AI-Augmented Fluoroscopic Navigation for Intraoperative Pulmonary Nodule Localization
Default Option Nudging Intervention to Improve the Adherence Rates of Cancer Screening
Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients
Coformulation of Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab (MK-3475) Monotherapy for Programmed Cell Death 1 Ligand 1 (PD-L1) Positive Metastatic Non-Small Cell Lung Cancer (MK-7684A-003, KEYVIBE-003)
Feasibility and Preliminary Performance of an AI Prototype for Digital ROSE During EBUS-TBNA and Peripheral TBNA: a Prospective Pilot Study (AI-ROSE-FEAS)
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
Deep Learning Time-Series Prediction of Long-Term Growth Patterns of Pulmonary Ground-Glass Nodules Using Serial CT
Construction and Feasibility Study of a Home-Based Intelligent Symptom Management Program for Lung Cancer Patients Receiving Combined Drug Therapy Based on Symptom Journey Profiling
Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study
Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC
Sputum Cytometry Analysis in Lung Cancer Screening After Professional Asbestos Exposure